Evidence map›Paper›PMID 31199481›Full record

ArticleBrain : a journal of neurology2019

Alzheimer's pathology targets distinct memory networks in the ageing brain.

Anne Maass, David Berron, Theresa M Harrison, Jenna N Adams, Renaud La Joie, Suzanne Baker, Taylor Mellinger, Rachel K Bell, Kaitlin Swinnerton, Ben Inglis and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 210 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Evaluation of [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hippocampal Total, Subregion, and Subfield Volume Alterations in Late-Life Depression.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Elevation in network dynamics amplifies amyloid-dependent tau pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  17. Article
  18. Alzheimer's Disease Pathologies Affect Dopaminergic Neural Mechanisms of Memory.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Anne MaassHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
David BerronGerman Center for Neurodegenerative Diseases, Magdeburg, 39120, Germany.
Theresa M HarrisonHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Jenna N AdamsHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Renaud La JoieMemory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Suzanne BakerMolecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Lab, Berkeley, 94720, USA.
Taylor MellingerHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Rachel K BellHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Kaitlin SwinnertonHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Ben InglisHenry H. Wheeler, Jr. Brain Imaging Center, University of California, Berkeley, Berkeley, CA 94720, USA.
Gil D RabinoviciMemory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Emrah DüzelGerman Center for Neurodegenerative Diseases, Magdeburg, 39120, Germany.
William J JagustHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
University of California, Berkeley · USUniversity of California, San Francisco · USGerman Center for Neurodegenerative Diseases · DEImaging Center · USLund University · SE

Funding

PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, YADONG · 2004 to 2018
$27.1M
Neural and Biochemical Mechanisms of Cognitive AgingR01AG034570 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI William J. Jagust · 2009 to 2026
$12.0M
Neuroscience Training Program at UC BerkeleyT32NS095939 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BATEUP, HELEN S. · 2016 to 2025
$6.3M
Mechanisms of Alzheimer's Disease Progression in the Aging BrainR01AG062542 · NIA · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI JAGUST, WILLIAM J. · 2019 to 2023
$4.2M
Early Age-of-Onset AD: Clinical Heterogeneity and Network DegenerationR01AG045611 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RABINOVICI, GIL DAN · 2014 to 2018
$3.1M
Tracking Tau with In Vivo Braak Staging: Longitudinal Analysis of Tau Pathology and Functional Sequelae in Cognitively Healthy Older AdultsF32AG057107 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARRISON, THERESA M. · 2017 to 2020
$124k
LAG1 HOMOLOG AND YEAST REPLICATIVE LIFE SPANF32AG005710 · NIA · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI KIRCHMAN, PAUL A · 1995 to 1997
–
NIA NIH HHS F32 AG005710NIA NIH HHS F32 AG057107NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG034570NIA NIH HHS R01 AG045611NIA NIH HHS R01 AG062542NINDS NIH HHS T32 NS095939
6 · The paper itself

Abstract

Alzheimer's disease researchers have been intrigued by the selective regional vulnerability of the brain to amyloid-β plaques and tau neurofibrillary tangles. Post-mortem studies indicate that in ageing and Alzheimer's disease tau tangles deposit early in the transentorhinal cortex, a region located in the anterior-temporal lobe that is critical for object memory. In contrast, amyloid-β pathology seems to target a posterior-medial network that subserves spatial memory. In the current study, we tested whether anterior-temporal and posterior-medial brain regions are selectively vulnerable to tau and amyloid-β deposition in the progression from ageing to Alzheimer's disease and whether this is reflected in domain-specific behavioural deficits and neural dysfunction. 11C-PiB PET and 18F-flortaucipir uptake was quantified in a sample of 131 cognitively normal adults (age: 20-93 years; 47 amyloid-β-positive) and 20 amyloid-β-positive patients with mild cognitive impairment or Alzheimer's disease dementia (65-95 years). Tau burden was relatively higher in anterior-temporal regions in normal ageing and this difference was further pronounced in the presence of amyloid-β and cognitive impairment, indicating exacerbation of ageing-related processes in Alzheimer's disease. In contrast, amyloid-β deposition dominated in posterior-medial regions. A subsample of 50 cognitively normal older (26 amyloid-β-positive) and 25 young adults performed an object and scene memory task while functional MRI data were acquired. Group comparisons showed that tau-positive (n = 18) compared to tau-negative (n = 32) older adults showed lower mnemonic discrimination of object relative to scene images [t(48) = -3.2, P = 0.002]. In a multiple regression model including regional measures of both pathologies, higher anterior-temporal flortaucipir (tau) was related to relatively worse object performance (P = 0.010, r = -0.376), whereas higher posterior-medial PiB (amyloid-β) was related to worse scene performance (P = 0.037, r = 0.309). The functional MRI data revealed that tau burden (but not amyloid-β) was associated with increased task activation in both systems and a loss of functional specificity, or dedifferentiation, in posterior-medial regions. The loss of functional specificity was related to worse memory. Our study shows a regional dissociation of Alzheimer's disease pathologies to distinct memory networks. While our data are cross-sectional, they indicate that with ageing, tau deposits mainly in the anterior-temporal system, which results in deficits in mnemonic object discrimination. As Alzheimer's disease develops, amyloid-β deposits preferentially in posterior-medial regions additionally compromising scene discrimination and anterior-temporal tau deposition worsens further. Finally, our findings propose that the progression of tau pathology is linked to aberrant activation and dedifferentiation of specialized memory networks that is detrimental to memory function.

Indexed as

AdultAgedAged, 80 and overAgingAlzheimer DiseaseAmyloid beta-PeptidesBrainCognitive DysfunctionCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMemoryMiddle AgedPositron-Emission TomographyAmyloid beta-Peptidestau Proteinsanterior-temporal (AT)hyperactivationmemoryposterior-medial (PM)tau

Identifiers

PMID31199481
PMCPMC6658874
OpenAlexW2953216263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.